Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Presse Medicale (Paris, France : 1983)
|
March 22, 1986
[Malignant non-Hodgkin's lymphoma associated with a serum monoclonal immunoglobulin]
J J Sotto, A Rueff, J C Bensa, et al.
Revue Neurologique
|
November 13, 2017
Is the Choosing Wisely<sup>®</sup> campaign model applicable to the management of multiple sclerosis in France? A GRESEP pilot study
B Trumbic, H Zéphir, J-C Ouallet, et al.
Immunology
|
January 1, 1984
Role of C3 in the control of monocyte C2 production
A O Hamilton, L Morrison, W S Kilpatrick, et al.
European Journal of Neurology
|
July 14, 2018
Acute idiopathic optic neuritis: not always benign
R Deschamps, A Gueguen, A Lecler, et al.
Archives Francaises De Pediatrie
|
August 1, 1983
[Erythroblastopenia in a child with immune deficiency and hyper IgM]
C Bachelot, P François, M Bost, et al.
European Journal of Immunology
|
December 1, 1995
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells
J Plumas, L Chaperot, M C Jacob, et al.
Transplantation
|
November 27, 1996
False-negative results in anti-HLA antibody detection by Sangstat ELISA: complement dependent cytotoxicity is not yet obsolete
A Pierquin, D Masson, O Toupance, et al.
Experimental Hematology
|
March 25, 1999
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas
L Chaperot, J Plumas, M C Jacob, et al.
American Journal of Hematology
|
January 1, 1992
CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD)
M C Jacob, M Favre, F Lemarc'Hadour, et al.
Revue Neurologique
|
April 2, 2014
Multiple sclerosis and pregnancy
E Bodiguel, C Bensa, D Brassat, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Presse Medicale (Paris, France : 1983)
|
March 22, 1986
[Malignant non-Hodgkin's lymphoma associated with a serum monoclonal immunoglobulin]
J J Sotto, A Rueff, J C Bensa, et al.
Revue Neurologique
|
November 13, 2017
Is the Choosing Wisely<sup>®</sup> campaign model applicable to the management of multiple sclerosis in France? A GRESEP pilot study
B Trumbic, H Zéphir, J-C Ouallet, et al.
Immunology
|
January 1, 1984
Role of C3 in the control of monocyte C2 production
A O Hamilton, L Morrison, W S Kilpatrick, et al.
European Journal of Neurology
|
July 14, 2018
Acute idiopathic optic neuritis: not always benign
R Deschamps, A Gueguen, A Lecler, et al.
Archives Francaises De Pediatrie
|
August 1, 1983
[Erythroblastopenia in a child with immune deficiency and hyper IgM]
C Bachelot, P François, M Bost, et al.
European Journal of Immunology
|
December 1, 1995
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells
J Plumas, L Chaperot, M C Jacob, et al.
Transplantation
|
November 27, 1996
False-negative results in anti-HLA antibody detection by Sangstat ELISA: complement dependent cytotoxicity is not yet obsolete
A Pierquin, D Masson, O Toupance, et al.
Experimental Hematology
|
March 25, 1999
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas
L Chaperot, J Plumas, M C Jacob, et al.
American Journal of Hematology
|
January 1, 1992
CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD)
M C Jacob, M Favre, F Lemarc'Hadour, et al.
Revue Neurologique
|
April 2, 2014
Multiple sclerosis and pregnancy
E Bodiguel, C Bensa, D Brassat, et al.
Page
of 9